0001209191-19-058217.txt : 20191126 0001209191-19-058217.hdr.sgml : 20191126 20191126200100 ACCESSION NUMBER: 0001209191-19-058217 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191122 FILED AS OF DATE: 20191126 DATE AS OF CHANGE: 20191126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Howton David T CENTRAL INDEX KEY: 0001529297 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 191252771 MAIL ADDRESS: STREET 1: VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-11-22 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001529297 Howton David T 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 EVP, General Counsel Common Stock 2019-11-22 4 M 0 5685 13.71 A 24388 D Common Stock 2019-11-22 4 M 0 4025 13.71 A 28413 D Common Stock 2019-11-22 4 M 0 8580 13.90 A 36993 D Common Stock 2019-11-22 4 S 0 18290 105.00 D 18703 D Common Stock 2019-11-22 4 S 0 3753 105.00 D 14950 D Common Stock 2019-11-22 4 S 0 2957 105.00 D 11993 D Common Stock 2019-11-22 4 M 0 2440 13.71 A 14433 D Common Stock 2019-11-22 4 M 0 52 13.71 A 14485 D Common Stock 2019-11-22 4 M 0 5590 13.90 A 20075 D Common Stock 2019-11-22 4 M 0 7900 23.85 A 27975 D Common Stock 2019-11-22 4 F 0 2804 107.02 D 25171 D Stock option (right to buy) 13.71 2019-11-22 4 M 0 5685 0.00 D 2017-02-28 2026-02-28 Common Stock 5685 1280 D Stock option (right to buy) 13.71 2019-11-22 4 M 0 4025 0.00 D 2016-09-19 2026-02-28 Common Stock 4025 1858 D Stock option (right to buy) 13.90 2019-11-22 4 M 0 8580 0.00 D 2016-02-27 2025-02-27 Common Stock 8580 18579 D Stock option (right to buy) 13.71 2019-11-22 4 M 0 2440 0.00 D 2017-02-28 2026-02-28 Common Stock 2440 2470 D Stock option (right to buy) 13.71 2019-11-22 4 M 0 52 0.00 D 2016-09-19 2026-02-28 Common Stock 52 18 D Stock option (right to buy) 13.90 2019-11-22 4 M 0 5590 0.00 D 2016-02-27 2025-02-27 Common Stock 5590 0 D Stock option (right to buy) 23.85 2019-11-22 4 M 0 7900 0.00 D 2013-11-05 2022-11-05 Common Stock 7900 5118 D This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. Represents shares of Common Stock owned by the reporting person that were delivered to the Company to pay the aggregate exercise price with respect to the option exercises reported in rows 4-7 in Table II of this Form 4 filing. /s/ David Tyronne Howton 2019-11-26